Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)

0.5405
Delayed Data
As of May 31
 -0.0495 / -8.39%
Today’s Change
0.45
Today|||52-Week Range
12.60
-63.97%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Fresh Tracks Therapeutics Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +2,120.17% increase from the last price of 0.54.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Fresh Tracks Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.68
Sales
$500.0K
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -47.37%
 
 
 
 
 
 
Growthannually 27.16%
 
 
 
 
 
 

Sales

Growthquarterly 5,455.56%
 
 
 
 
 
 
Growthannually -13.58%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.